As thousands of people await a lifesaving heart, scientists are racing to buy them more time. A promising advance from scientists in Germany offers a potential solution.

The identification and management of comorbidities are central to the care of patients with atrial fibrillation (AF). The ...

Blood clots are associated with life-threatening conditions such as sepsis, sickle cell disease, heart attack, and stroke.

Among all U.S. hospitals, only 29 had better heart failure mortality rates and lower payments for heart failure care compared to national averages between July 1, 2020, and June 30, 2023, according to ...

There are over six million Americans with heart failure who are at greater risk of losing their cognitive abilities earlier ...

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable ...

To study the possible consequences of paternal cardiac damage to the next generation, males underwent cardiac cryoinjury at ...

Medera announced that updated results from its ongoing MUSIC-HFpEF Phase 1/2a clinical trial investigating SRD-002, a one-time gene therapy ...

Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing ...

BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) has become the most prevalent type of heart failure, but ...

The prospect of Lyme disease is no joke. About 47% of the adult ticks that the St. Joseph County Department of Health has ...

The following is a summary of "Association of triglyceride-glucose index trajectories with the risk of worsening heart ...